Percutaneous Transluminal Angioplasty Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorKlinik für Kardiologie, Pneumologie und Angiologie
About this trial
Percutaneous transluminal angioplasty (PTA) is a minimally invasive procedure for dilating blood vessels in the treatment of peripheral artery disease.
The aim of this registry is to collect prospectively and systematically clinical research data from patients undergoing PTA. This registry is an open-end observational study to assess the characteristics and outcomes in patients with undergoing PTA.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients undergoing PTA
Disqualifiers
< 18 years
Trial population
Patients undergoing PTA
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Patency rate
Time frame
6 months2
Creatinine level
Time frame
2 Days after PTASecondary outcomes
1
Mortality
Time frame
30 days2
Days of Hospitalization
Days of Hospitalization at 12 months
Time frame
12 months3
Ankle-Brachial Index
Clinical Improvement measured by Ankle-Brachial Index
Time frame
6 months and 12 months4
walking distance
Clinical Improvement measured by walking distance
Time frame
6 months and 12 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Klinik für Kardiologie, Pneumologie und Angiologie
Lead sponsor
Heinrich-Heine University, Duesseldorf
Sponsor institution
Source ClinicalTrials.gov